NRX Pharmaceuticals Inc (NRXP)

[dmsrz8]

Look, the only thing here in debate is the issue with the patent. Relief owns the patent on the formulation of Aviptadil. NeuroRX has trademarked that formulation as Zyesami. However that only is done to protect the name and selling of the formulation that Relief still owns the patent to. This is all marketing and nothing more. At the end of the day, the formula is owned by Relief, and the variation of formula is patent protected for Relief. All NRX can do is create the naming for sales. Profit sharing across the globe has already been agreed to.